2oz 3oz 4oz UV Protection Smell Proof Child Resistant Magnifying Glass Jar
Wide Mouth Glass Bottle Container Smell Proof Child Resistant Glass Jars with Magnifying Lids
Wide Mouth Glass Bottle Container Smell Proof Child Resistant Glass Jars with Magnifying Lids
Child resistant plastic tube 1. This tube just has two fixed sizes. 2. We can customized colors, logos, labels and so on. 3. It's squeeze Pop Top cap. And tubes can be used to package.
Product Display Product detail Product introduction UV Protection and Longevity: these roller bottles for oils are made from robust and thick glass coupled with stainless steel for roller balls and caps, ensuring longevity; The material ensures the bottles remain well protected against shocks or impacts, proper for long term use; And the bottles can protect against UV rays which are harmful to essential oils. Compact Size for Portability: with a size of approximately 10ml, these glass roller bottles for oils offer convenience for carrying around; This portable size means you can easily place these bottles in your purse, pocket, or handbag, making it an ideal choice when traveling, for office use, or even in the home. Versatile Usage: these perfume roller bottles are versatile and suitable for different applications; Use them to store diluted essential oils, perfume oils, blends, or other liquids. They're proper to satisfy your daily skincare needs, from the face to your body; Whether a...
Herb Tin Can The tin can be sealed at home with only your hands! After the ring has been pulled, they can then be re-sealed with the plastic cap, to keep your product fresh! Available with black, clear, or white plastic lid caps. Wholesale options available. Stores up to 100ml/3.5gram (1/8oz)of products. Diameter: 73mm (2.9 inches), Height: 23mm (0.9 inch). One set includes : 1 x Silver tin (stores up to 100ml/3.5g of product) 1 x Bottom Base Cover 1 x Black or Clear Plastic Lid Self sealing - No tools required, just push & Ring in the bottom. Designed to hand seal your Flower Bud to keep them safe and fresh. Ideal for dry foods, consumer products, laboratories, field work, and packaging novelty items. (Flower Buds, Dry Flowers Dry food. Confectionary. Nuts. Confetti. Socks. Limited edition products.) Sample delivery Wholesale options available. For large orders, and for shipments, please contact us for a custom quote. If need Self Seal Tin Cans, please give us your delivery ...
Recently, a startup company called Pico IV in California, USA, received a severe warning letter from the FDA (Food and Drug Administration) for selling intravenous CBD products as "dietary supplements," instantly sparking discussions in the health product industry. It is reported that Pico IV claims to provide the world's first injectable CBD product. This product is a high-purity CBD (cannabidiol) designed specifically for intravenous infusion into the bloodstream.
This Sacramento based company promotes the treatment of chronic pain, Crohn's disease, and arthritis on its official website, and provides multiple "recommendation letters" as evidence. However, in the warning letter issued by the FDA last Monday, the FDA explicitly stated that Pico IV's marketing of this injectable product as a "dietary supplement" is illegal. The FDA explicitly states: Classification error: According to the Federal Food, Drug, and Cosmetic Act (FD&C Act), injectable products do not meet the definition of "dietary supplements" (limited to oral form only) and must be declared as drugs or biologics. Safety risk: If intravenous injection products fail the sterility and stability review, they may lead to fatal risks such as sepsis and thrombosis. Violation of efficacy claims: The official website mentions that "treating chronic diseases" is a drug efficacy claim that requires clinical data support.
Toxicologists point out that CBD injections may pose contamination risks: cannabis plants are prone to adsorbing heavy metals and pesticides, and even if third-party testing is qualified, the purity standards for injections are much higher than those for oral products (which must comply with USP<797>sterile formulation specifications). However, supporters believe that if injectable CBD is marketed in compliance, it can fill the gap in the pain management market. According to data from Brightfield Group, the size of the CBD market in the United States alone is expected to reach $6 billion in 2023, with the medical sector accounting for over 40%. The demand for alternative therapies among patients continues to grow.
In response to the FDA's warning, Pico IV CEO Joe Young quickly responded. In an email statement sent to SFGATE, he stated, "Public safety is our top priority," and emphasized that the company's products have undergone strict processes aimed at ensuring sterility and safety: "We are confident in the safety of our products and are working to provide necessary information to the FDA to address their concerns. However, the FDA believes that its marketing model still carries the risk of misleading consumers and medical institutions.
Pico IV, headquartered in Sacramento, California, was founded in 2020 by biotechnology expert Joe Young. The company's mission is to revolutionize the delivery of cannabinoids, focusing on developing high-purity and highly bioavailable cannabinol (CBD) products. Its core team consists of pharmaceutical engineers, toxicologists, and clinical doctors, dedicated to expanding the application of medical marijuana from traditional oral and topical use to intravenous injection. According to the official website, Pico IV's patented technology uses supercritical CO ₂ extraction process combined with nano purification technology to produce CBD crystals with a purity of 99.9%. The product claims to have direct access to the circulatory system through intravenous injection, with a bioavailability of 95% (far exceeding the 6% -15% for oral administration), targeting patients with chronic pain, Crohn's disease, and arthritis. At present, the product is only sold through authorized medical clinics and practicing doctors, priced at $150-300 per injection.